title: Conflicting information from TGA versus FDA may undermine compliance with use of medication.
authors.forename: Klaus Martin
authors.initials: KM
authors.lastname: Beckmann
mesh_terms: D000293:Adolescent; D058647:Adrenergic alpha-2 Receptor Agonists / Q000627:therapeutic use*; D000367:Age Factors; D001289:Attention Deficit Disorder with Hyperactivity / Q000188:drug therapy*; D001315:Australia; D002648:Child; D003000:Clonidine / Q000627:therapeutic use*; D017277:Drug Approval; D004348:Drug Labeling; D006801:Humans; D010349:Patient Compliance; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D058647:Adrenergic alpha-2 Receptor Agonists; D003000:Clonidine